HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases.

Abstract
Topical or intralesional corticosteroids are referred to as gold standard treatments for keloids. Recent studies showed that ablative fractional laser (AFL) treatment facilitates delivery of topical drug deeply into the skin by creating vertical channels. The objective of the present study was to assess the ablative erbium laser in fractionated mode, combined with topical high potent corticosteroid cream for treating resistant keloid scars. We conducted a retrospective study in the laser center of the Department of Dermatology (University Hospital of Nice, France), from January 2010 to June 2012, on patients with keloids who were resistant to a first-line of treatment. A 2940-nm ablative fractional erbium laser was used. Topical betamethasone cream was applied twice a day under occlusion with transparent film dressings. A total of 23 patients with 70 keloids were treated from January 2010 to June 2012. The median percentage of improvement was 50% (range -43 to 84). The mean follow-up was 8 months (range 3-18), and a recurrence was observed for eight lesions (22%). Although this observation warrants a prospective comparative evaluation, it supports the interest of the laser-assisted delivery of steroids for treating keloids scars.
AuthorsMarine Cavalié, Laura Sillard, Henri Montaudié, Philippe Bahadoran, Jean-Philippe Lacour, Thierry Passeron
JournalDermatologic therapy (Dermatol Ther) 2015 Mar-Apr Vol. 28 Issue 2 Pg. 74-8 ISSN: 1529-8019 [Electronic] United States
PMID25471297 (Publication Type: Journal Article)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Glucocorticoids
  • Betamethasone
Topics
  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Betamethasone (administration & dosage)
  • Child
  • Drug Delivery Systems (instrumentation)
  • Female
  • France
  • Glucocorticoids (administration & dosage)
  • Hospitals, University
  • Humans
  • Keloid (diagnosis, drug therapy)
  • Lasers, Solid-State
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Skin (drug effects, pathology)
  • Time Factors
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: